Clinical trial
Provider Referral Patterns Following Nephrectomy in High-Risk Locoregional Renal Cell Carcinoma
NCT04309617 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Provider Referral Patterns Following Nephrectomy in High-Risk Locoregional Renal Cell Carcinoma
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2019
- Completion date
- April 28, 2020
- Enrollment
- 618 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma